Sunovion Pharmaceuticals Senior UI/UX Designer Salaries in Wilmington, DE
The average Sunovion Pharmaceuticals Senior UI/UX Designer in Wilmington, DE earns an estimated $98,768 annually, which includes an estimated base salary of $92,268 with a $6,500 bonus. Sunovion Pharmaceuticals' Senior UI/UX Designer compensation is $20,477 less than the US average for a Senior UI/UX Designer. Senior UI/UX Designer salaries at Sunovion Pharmaceuticals in Wilmington, DE can range from $82,000 - $120,000.
In Wilmington, DE, The Design Department at Sunovion Pharmaceuticals earns $3,979 more on average than the Business Development Department.
Last updated 3 years ago.
- $92,268
- avg. base
- $6,500
- avg. bonus
Senior UI/UX Designer Salaries at Sunovion Pharmaceuticals
In Wilmington, DE, Senior UI/UX Designers earn $129 more than UI/UX Designers, and $28,264 less than Senior Designers.
Compensation at Sunovion Pharmaceuticals by Department
In Wilmington, DE, The Design Department averages $3,979 more than the Business Development Department, and $295 less than the HR Department
Senior UI/UX Designer Compensation by Gender (All Companies)
The average female Senior UI/UX Designer at companies similar size to Sunovion Pharmaceuticals reported making $121,081, while the average male Senior UI/UX Designer at similar sized companies reported making $131,498.
Senior UI/UX Designer Compensation by Ethnicity (All Companies)
The average African American/Black Senior UI/UX Designer at companies similar size to Sunovion Pharmaceuticals reported making $134,750, while the average Hispanic or Latino Senior UI/UX Designer at similar sized companies reported making $120,353.
How Senior UI/UX Designers at Sunovion Pharmaceuticals Rate Their Compensation
The majority of Senior UI/UX Designers at Sunovion Pharmaceuticals believe they're not compensated fairly. 67% of Senior UI/UX Designers at Sunovion Pharmaceuticals say they receive annual bonuses, and the vast majority (80%) are satisfied with their benefits. See more compensation ratings at Sunovion Pharmaceuticals
